文献速递母胎医学

多种临床指征孕妇中非侵入性产前检测检出21、18、13三体的多中心观察研究:中国1,854,148例孕妇分析

Non-invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: A multicenter observational study of 1,854,148 women in China.
PubMed 文献 · Prenat Diagn · 2023-01-27

该研究基于中国约300个产前诊断中心的国家级横断面调查,纳入2016年10月1日至2018年9月30日共1,854,148例孕妇,评估NIPT在七种临床指征下对T21、T18、T13的检测性能。总体检出率为0.31%(95%CI:0.30%-0.32%),NIPT对三种三体的敏感性为99.60%-100%、特异性为99.90%-99.95%,但阳性预测值(PPV)随临床指征不同在9.09%-66.46%之间波动,作者指出需加强产前筛查教育与遗传咨询。

要点

  • NIPT对T21、T18、T13的敏感性分别为99.60%、99.14%、100%,特异性分别为99.90%、99.94%、99.95%。
  • 总体检出率0.31%(95%CI:0.30%-0.32%),阳性病例多见于「NT增厚」(1.18%)和「高龄妊娠」(0.51%)。
  • 三种三体的PPV在不同临床指征间差异大,范围9.09%-66.46%。

核心结论

  • NIPT在不同临床指征孕妇中对T21、T18、T13均显示高敏感性和高特异性,但PPV强烈依赖于临床指征,作者强调需加强产前筛查教育和遗传咨询。

研究设计与样本

  • 国家级横断面调查,覆盖约300个产前诊断中心,通过产前诊断技术管理在线信息系统收集2016年10月1日至2018年9月30日数据,共纳入1,854,148例孕妇,按七种临床指征分析NIPT对T21、T18、T13的检测性能。

主要发现

  • 1,854,148例样本中检出5,766例T21、T18、T13真阳性,总体检出率0.31%(95%CI:0.30%-0.32%),阳性病例多见于「NT增厚」(1.18%)和「高龄妊娠」(0.51%)。
  • NIPT对T21、T18、T13的敏感性分别为99.60%、99.14%、100%,特异性分别为99.90%、99.94%、99.95%,PPV分别为69.77%、47.24%、22.36%。
  • 七种临床指征下,T21的PPV范围为50.62%-73.09%,T18为20.00%-58.33%,T13为4.17%-47.37%,三种三体PPV总体范围9.09%-66.46%。
  • PPV最高值:T21为73.09%(高龄妊娠),T18为58.33%(NT增厚),T13为47.37%(NT增厚)。

临床怎么用

  • 作者认为,NIPT在不同临床指征孕妇中对T21、T18、T13检测显示高敏感性和高特异性,但PPV取决于临床指征,需加强产前筛查教育和遗传咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the performance of noninvasive prenatal testing (NIPT) for detecting three common trisomies (T21, T18, and T13) in pregnant women with diverse clinical indications. METHODS: Frequencies of NIPT, of high chance of having one of the three trisomies, and of confirmed trisomies were determined for women with each of seven clinical indications in a national cross-sectional survey of approximately 300 prenatal diagnosis centers. Data were collected for the period from October 1, 2016 to September 30, 2018 using the Prenatal Diagnosis Technology Management On-line Information System. The performance of NIPT for detecting the three trisomies in pregnant women with different clinical indications was assessed in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value, and the corresponding 95% confidence intervals. RESULTS: A total of 5766 true positive cases for T21, T18, and T13 were detected among 1,854,148 samples, giving an overall detection rate of 0.31% (95% CI: 0.30%-0.32%). Most positive cases were associated with "NT thickening" (1.18%) and "advanced maternal age" (0.51%). The detection sensitivities of NIPT were 99.60% for T21, 99.14% for T18, and 100% for T13, while the corresponding specificities were 99.90%, 99.94%, and 99.95%. The corresponding PPVs were 69.77%, 47.24%, and 22.36%. NIPT showed high sensitivity and specificity, regardless of clinical indication. In contrast, PPV for three trisomies varied widely between 9.09% and 66.46% depending on the clinical indication. Across seven clinical indications, PPV ranged from 50.62% to 73.09% for T21, 20.00%-58.33% for T18, and 4.17%-47.37% for T13. The highest PPVs were 73.09% for T21 in pregnancies involving "advanced maternal age", 58.33% for T18 in pregnancies with "NT thickening", and 47.37% for T13 in pregnancies with "NT thickening". CONCLUSIONS: NIPT shows high sensitivity and specificity for detecting T21, T18, and T13 in pregnant women with different clinical indications. However, PPV depends strongly on clinical indication, highlighting the need to strengthen education and genetic counseling about prenatal screening.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Xiang L, Zhu J, Deng K, et al. Non-invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: A multicenter observational study of 1,854,148 women in China. Prenat Diagn. 2023. PMID: 36639250. doi:10.1002/pd.6312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。